Cargando…
Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203368/ https://www.ncbi.nlm.nih.gov/pubmed/35179641 http://dx.doi.org/10.1007/s00277-022-04792-0 |
| _version_ | 1784728699465105408 |
|---|---|
| author | Davies, Faith E. Saunders, Eleanor Bourhis, François Guyot, Patricia |
| author_facet | Davies, Faith E. Saunders, Eleanor Bourhis, François Guyot, Patricia |
| author_sort | Davies, Faith E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9203368 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92033682022-06-18 Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” Davies, Faith E. Saunders, Eleanor Bourhis, François Guyot, Patricia Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-02-18 2022 /pmc/articles/PMC9203368/ /pubmed/35179641 http://dx.doi.org/10.1007/s00277-022-04792-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Davies, Faith E. Saunders, Eleanor Bourhis, François Guyot, Patricia Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title | Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title_full | Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title_fullStr | Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title_full_unstemmed | Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title_short | Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| title_sort | re: arcuri and americo “treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203368/ https://www.ncbi.nlm.nih.gov/pubmed/35179641 http://dx.doi.org/10.1007/s00277-022-04792-0 |
| work_keys_str_mv | AT daviesfaithe rearcuriandamericotreatmentofrelapsedrefractorymultiplemyelomainthebortezomibandlenalidomideeraasystematicreviewandnetworkmetaanalysis AT saunderseleanor rearcuriandamericotreatmentofrelapsedrefractorymultiplemyelomainthebortezomibandlenalidomideeraasystematicreviewandnetworkmetaanalysis AT bourhisfrancois rearcuriandamericotreatmentofrelapsedrefractorymultiplemyelomainthebortezomibandlenalidomideeraasystematicreviewandnetworkmetaanalysis AT guyotpatricia rearcuriandamericotreatmentofrelapsedrefractorymultiplemyelomainthebortezomibandlenalidomideeraasystematicreviewandnetworkmetaanalysis |